Olema Pharmaceuticals Shares Slip After CFO Announces Exit
Olema Pharmaceuticals Inc. saw its stock decline in after-hours trading following the announcement that Chief Operating and Financial Officer Shane Kovacs will depart the company effective January 30, 2026. Kovacs will remain on a consulting basis through August 1, 2026. CEO Sean P. Bohen has taken on the interim Principal Financial Officer role as…